ABSTRACT
INTRODUCTION: malnutrition is a very frequent problem in oncology patients and can have serious repercussions. Adequate nutritional management is cost-effective in terms of health and survival in this population, but it requires multidisciplinary coordination, specific training, and continuous follow-up. OBJECTIVE: to validate the applicability and efficacy of a multidisciplinary nutritional support protocol in oncology patients. METHODS: a multidisciplinary nutritional protocol was developed for oncology patients, with guidelines for screening and assessment of malnutrition, treatment, re-evaluation, and management of side effects, as well as guidance on supplementation and eating patterns. The protocol would be implemented in various clinical centers, collecting data through a structured questionnaire, registering variables before and after implementation. RESULTS: the protocol and its impact were implemented and evaluated in 39 centers. An improvement in nutritional care was observed, evidenced by an earlier initiation of nutritional assessment and an increase in the number of patients receiving adequate care following the protocol implementation. Problems related to inadequate malnutrition coding in the centers, limited resources, and the need for greater interdepartmental collaboration were identified. CONCLUSIONS: the conduct of this study provides insights into how the implementation of a multidisciplinary nutritional support protocol can improve the nutritional care received by patients and informs about the main obstacles to adequate implementation.
Subject(s)
COVID-19 , Neoplasms , Radiation Oncology , Humans , Neoplasms/radiotherapy , SARS-CoV-2 , SpainABSTRACT
The aim of this study is to assess the results of episcleral brachytherapy as treatment of retinal vasoproliferative tumors (RVTs) in a referral Intraocular Tumors Unit (ITU). A retrospective review of all patients diagnosed with vasoproliferative tumors of the retina and treated with episcleral brachytherapy in the ITU, University Hospital of Valladolid between 2009 and 2015 was done. Five patients accomplished the inclusion criteria. All of them presented associated exudation and secondary retinal detachments (RD). Four patients had received prior treatments. Decreased tumor size and exudation regression was found in all cases after treatment. Visual acuity remained stable or increased in all patients. No recurrences have been found after twelve-months follow up. The results of the present study suggest that episcleral brachytherapy is an efficient and safe option in the management of vasoproliferative tumors, especially when large tumor or extensive subretinal fluid is present. In these cases episcleral brachytherapy could be considered as a first line treatment.
ABSTRACT
Realizamos una revisión de la radioterapia externa como medida de rescate en la recidiva bioquímica tras prostatectomía radical. Una vez definida la recidiva postprostatectomía se analizan los factores de riesgo de recidiva local y sistémica y la valoración del paciente que va a ser sometido a radioterapia externa como medida de rescate aportando argumentos a favor. Las nuevas técnicas en radioterapia externa, las dosis y volúmenes nos ayudan a definir los campos de tratamiento minimizando la toxicidad y mejorando la calidad del paciente. Analizamos la bibliografía para la mejora del enfoque terapéutico, basándonos en los datos actuales conocidos, a la espera de realización de nuevos ensayos clínicos(AU)
We review salvage external beam radiotherapy for biochemical recurrence after radical prostatectomy. Having defined recurrence, we analyze the risk factors of local recurrence and systemic evaluation of patients scheduled to undergo salvage radiotherapy. New techniques in external radiation, doses and volumes help us to define the areas minimizing treatment toxicity and improving the quality of the patient. We analyzed the literature to improve the therapeutic approach, based on currently known data, pending completion of further clinical trials. We describe a review about radiotherapy in biochemical failure after radical prostatectomy(AU)
